Anna Maestroni
Overview
Explore the profile of Anna Maestroni including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
40
Citations
822
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Ben Nasr M, Usuelli V, Dellepiane S, Seelam A, Fiorentino T, DAddio F, et al.
Cell Metab
. 2024 Jun;
36(6):1302-1319.e12.
PMID: 38838642
Glucagon-like peptide-1 receptor (GLP-1R) is a key regulator of glucose metabolism known to be expressed by pancreatic β cells. We herein investigated the role of GLP-1R on T lymphocytes during...
2.
DAddio F, Assi E, Maestroni A, Rossi G, Usuelli V, Petrazzuolo A, et al.
Front Endocrinol (Lausanne)
. 2024 Feb;
15:1306127.
PMID: 38318298
Pancreatic beta cells replenishment is considered the next therapeutic option for type 1 diabetes; while stimulating endogenous beta cells proliferation is the "holy grail" for those patients with exhausted beta...
3.
Petrazzuolo A, Sabiu G, Assi E, Maestroni A, Pastore I, Lunati M, et al.
Pharmacol Res
. 2023 Mar;
190:106710.
PMID: 36871895
Diabetic kidney disease (DKD) is the first cause of end-stage kidney disease in patients with diabetes and its prevalence is increasing worldwide. It encompasses histological alterations that mainly affect the...
4.
DAddio F, Pastore I, Loretelli C, Valderrama-Vasquez A, Usuelli V, Assi E, et al.
Acta Diabetol
. 2022 Jun;
59(9):1157-1167.
PMID: 35729357
Aims: Abnormalities in the oculomotor system may represent an early sign of diabetic neuropathy and are currently poorly studied. We designed an eye-tracking-based test to evaluate oculomotor function in patients...
5.
DAddio F, Sabiu G, Usuelli V, Assi E, Abdelsalam A, Maestroni A, et al.
Diabetes
. 2022 May;
71(8):1800-1806.
PMID: 35551366
Patients with type 1 diabetes (T1D) may develop severe outcomes during coronavirus disease 2019 (COVID-19), but their ability to generate an immune response against the SARS-CoV-2 mRNA vaccines remains to...
6.
Ben Nasr M, DAddio F, Montefusco L, Usuelli V, Loretelli C, Rossi A, et al.
Diabetes
. 2022 May;
71(7):1579-1590.
PMID: 35499468
Recent studies have shown that severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection may induce metabolic distress, leading to hyperglycemia in patients affected by coronavirus disease 19 (COVID-19). We investigated...
7.
DAddio F, Maestroni A, Assi E, Ben Nasr M, Amabile G, Usuelli V, et al.
Nat Commun
. 2022 Feb;
13(1):684.
PMID: 35115561
Loss of pancreatic beta cells is a central feature of type 1 (T1D) and type 2 (T2D) diabetes, but a therapeutic strategy to preserve beta cell mass remains to be...
8.
Loretelli C, Abdelsalam A, DAddio F, Ben Nasr M, Assi E, Usuelli V, et al.
JCI Insight
. 2021 Nov;
6(24).
PMID: 34784300
A substantial proportion of patients who have recovered from coronavirus disease-2019 (COVID-19) experience COVID-19-related symptoms even months after hospital discharge. We extensively immunologically characterized patients who recovered from COVID-19. In...
9.
Pastore I, Assi E, Ben Nasr M, Bolla A, Maestroni A, Usuelli V, et al.
Front Immunol
. 2021 Jul;
12:694118.
PMID: 34305929
Despite the increasing knowledge of pathophysiological mechanisms underlying the onset of type 1 diabetes (T1D), the quest for therapeutic options capable of delaying/reverting the diseases is still ongoing. Among all...
10.
Loretelli C, Rocchio F, DAddio F, Ben Nasr M, Castillo-Leon E, Dellepiane S, et al.
Metabolism
. 2021 Jun;
121:154804.
PMID: 34097917
Aims/hypothesis: Inflammation has a major role in diabetic kidney disease. We thus investigated the role of the IL-8-CXCR1/2 axis in favoring kidney damage in diabetes. Methods: Urinary IL-8 levels were...